Genetic Landscape of Hereditary Spastic Paraplegia in Iran: Insights from Novel variants and Genotype-Phenotype Correlations
This study analyzes 74 Iranian patients with hereditary spastic paraplegia using exome sequencing, achieving an 80% molecular diagnostic rate, identifying a high proportion of novel variants with *SPG11* as the most frequent mutated gene, and establishing diverse genotype-phenotype correlations to better understand the disease's genetic landscape in this population.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Hereditary spastic paraplegia is a group of rare neurological conditions where the long nerve fibers connecting the brain to the legs slowly break down. Imagine these fibers as the main cables carrying signals for movement; when they deteriorate, the legs become stiff and weak, making walking difficult or impossible over time. While the disease affects the body's ability to move, it often brings other challenges as well, such as intellectual disability, speech problems, or seizures, depending on which specific genetic instructions are broken. Scientists have discovered that this condition is caused by errors in dozens of different genes, but because these errors are so varied and the symptoms so complex, it has been difficult to map exactly which mistake causes which specific outcome, especially in populations that have not been studied in depth before.
In a comprehensive nine-year study, researchers in Iran set out to fill this gap by examining the genetic code of 74 patients diagnosed with hereditary spastic paraplegia. The team, working across two major medical centers, used a powerful technique called exome sequencing, which reads the specific parts of DNA that contain instructions for making proteins. By analyzing the blood samples of these patients and their families, the scientists were able to identify the exact genetic cause in 60 of the 74 individuals, achieving a diagnostic success rate of 80 percent. This high level of success suggests that for this specific population, looking at the entire set of protein-making genes is far more effective than testing for just a few known errors. The study revealed that the most common genetic culprit was a gene called SPG11, which was responsible for the condition in nearly nine percent of the cases, followed by several other genes involved in cellular transport and maintenance.
What makes this research particularly valuable is the discovery of 26 brand-new genetic errors among the 58 distinct variants identified, which had never been seen before in scientific databases. These findings expand the known map of the disease, showing that the genetic landscape in Iran is distinct and diverse. The researchers found that nearly half of the genetic variants they identified were unique to their study, with many of these new errors located in critical sections of the proteins where even a small change can cause the system to fail. The study also clarified how these different genetic mistakes translate into real-world symptoms. For instance, while some genetic errors led to a "pure" form of the disease affecting only movement, the majority of patients in this group, about 90 percent, had a "complex" form involving additional issues like developmental delays, speech difficulties, and intellectual disability. This aligns with the high rate of marriage between relatives in the studied families, a factor that tends to bring out recessive genetic conditions that often present with more severe symptoms.
The team also observed how specific changes in the DNA led to different outcomes, even within the same gene. In the case of the SPG11 gene, which is usually associated with severe complications, two patients with specific types of genetic errors had the milder "pure" form of the disease, while others with different errors in the same gene had the severe "complex" form. This suggests that the exact nature of the genetic mistake matters just as much as which gene is affected. Furthermore, the study highlighted that the average age at which symptoms began was significantly younger in this Iranian group compared to reports from Western populations, likely due to the genetic structure of the families involved. By identifying these specific patterns and new variants, the researchers have provided a clearer picture of the disease for Iranian families, offering a path toward more accurate diagnosis and better genetic counseling, while also revealing that the biological mechanisms of this disease are more varied than previously understood.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.